Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Mr. James Mackin est le Chairman of the Board de Artivion Inc, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action AORT ?
Le prix actuel de AORT est de $35.7, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Artivion Inc ?
Artivion Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Artivion Inc ?
La capitalisation boursière actuelle de Artivion Inc est de $1.7B
Est-ce que Artivion Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 9 analystes ont établi des notations d'analystes pour Artivion Inc, y compris 4 achat fort, 7 achat, 2 maintien, 0 vente et 4 vente forte